Adverse drug reactions
1 paper
- Animals1
Latest
8 in 12 monthsFrontiers in Cardiovascular Medicine
Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom
Cohort study of 237 peopleDapagliflozin
American Journal of Translational Research
Liraglutide in combination with zoledronic acid and calcium carbonate and vitamin D3 for diabetic osteoporosis: efficacy and glycometabolism impact
Non-randomised trial in 99 peopleLiraglutide
JCEM Case Reports
Postmenopausal bleeding associated with semaglutide: a diagnostic challenge
Case reportSemaglutide
Obesity Research & Clinical Practice
A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan
Cohort study of 41 peopleGLP-1 receptor agonists
European Journal of Hospital Pharmacy
Semaglutide-associated agranulocytosis requiring hospitalisation and granulocyte colony-stimulating factor: a case report
Case reportSemaglutide
Preprints.org
Real-World Effectiveness, Safety, and Use Patterns of GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes: A Nationwide Multicentre Community Pharmacy Study
Preprint: cross-sectional study of 531 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Extended-Interval PG-102, a GLP-1/GLP-2 Bispecific Agonist, in Adults with Type 2 Diabetes
Randomised trial in 48 peopleType 2 diabetes
Nature Communications
Odoribacter splanchnicus rescues aging-related intestinal P-glycoprotein damage via GDP-L-fucose secretion
Experiments in miceGut and microbiome